Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.
Lechel
André
A
Department of Gastroenterology, Hepatology, and Endocrinology, Medical School Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Manns
Michael P
MP
Rudolph
K Lenhard
KL
D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics*; D043171:Chromosomal Instability; D042522:DNA Replication Timing; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics*; D008113:Liver Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics*; D019098:Telomerase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D016615:Telomere / Q000235:genetics*
D004791:Enzyme Inhibitors; D019098:Telomerase